Clinical Trial Update: Administration of IV Laronidase Post Bone Marrow Transplant in Hurler [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intravenous laronidase administration after bone marrow transplant in Hurler syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hurler Syndrome

Drugs mentioned

• Laronidase (iduronidase)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Hurler Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2020-03-20